We use leading-edge technology and combine it with a deep understanding of disease biology. The result are biomarkers and diagnostic solutions that improve patient outcomes for acute care and preventive medicine: Our diagnostic solutions provide actionable insights in real-time for underserved medical conditions. A career at SphingoTec is not just a job – it´s a life pursuit in the service of a better patient care.
We drive innovation
SphingoTec GmbH develops and markets innovative IVD tests for novel and proprietary biomarkers. These tests enable the diagnosis, prediction and monitoring of acute medical conditions, such as septic shock and circulatory failure, acute heart failure and acute kidney injury in order to support patient management and provide guidance for treatment strategies. Our approach is hypothesis-driven and builds on a deep understanding of disease biology.
Our immunoassay portfolio
Our assay portfolio includes sphingotest® bio-ADM® the assay for bioactive adrenomedullin, a unique biomarker for real-time assessment of endothelial function in conditions like sepsis or congestive heart failure and sphingotest® penKid®, the assay for proenkephalin, a unique biomarker for real-time assessment of kidney function. We market these tests as point-of-care assays on the Nexus IB10 immunoassay platform as well as on a microtiter plate based format. Our point-of-case solutions are complemented by a broad portfolio of other assays that are already standard-of-care in acute care.
Are you interested in an open position? Then we look forward to receiving your application. We are constantly looking for highly motivated professionals to complement and expand our team.